Boehringer Ingelheim Pharmaceuticals Inc. regulatory update

The FDA's Peripheral & Central Nervous System Drugs Advisory Committee voted unanimously to recommend approval of Aggrenox extended-release dipyridamole capsules to prevent recurrent stroke in patien...